NAGE vs SLB · P/E 59, rev $61.3M vs P/E 12, rev $8.97B
Niagen Bioscience, Inc. (NAGE) versus Schlumberger NV (SLB) — a side-by-side from cached financials, not a winner call.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
Schlumberger NV (SLB) is a oil & gas equipment & services company listed on US.
Latest reported NAGE revenue for 2026-06-30 was $61.3M. Net income was $7.3M. Revenue was up 94.6% from 2026-03-31 to 2026-06-30. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Latest reported SLB revenue for 2026-06-30 was $8.97B. Net income was $786.0M. Revenue was up 2.9% from 2026-03-31 to 2026-06-30. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
NAGE currently screens at market cap $836.5M and trailing P/E 59.0. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
Not investment advice. Open the NAGE and SLB stock pages for the full models.
Not investment advice.